Ireland
--:--IST
Latest
Clinical Trials in Canada / NCT07647913
Starting soon Not applicable

Rhythm Psychophysics With Parkinson's Patients

NCT07647913 · tracked via the Priya Life Science Canada tracker
Phase
Not applicable
Started
2026-09-01
Last updated
2026-06-15

Condition(s) studied

Parkinson Disease(PD)

Investigational drug(s) / intervention(s)

Withholding Levodopa

Withholding Levodopa: Participants will have to withhold Levodopa medication 12 h before one of two experimental sessions.

Study summary

The goal of this interventional study is to understand how the rhythmic abilities of individuals in the early stages of Parkinson's Disease (PD) are impacted by their levels of dopamine. The main questions it aims to answer are:

* Does dopamine shelter the ability to generate and maintain a regular tapping rhythm in the presence of disrupting sensory information?
* Does dopamine allow the adaptation of tapping speed in the presence of changing sensory information?
* Is the engagement of the motor system useful to improve the detection of changes in the tempo of sensory information?

Participants will be asked to perform a battery of simple rhythmic tasks On and Off medication to evaluate the effect of dopamine on their rhythmic skills.

Eligibility

Sex
ALL
Min age
40 Years
Max age
80 Years
Healthy volunteers
No
Inclusion Criteria: * Parkinson's Disease diagnostic * Stage 1 or 2 Hoenh-Yahr scale * Taking immediate-release Levodopa * MoCA score of 26 or above Exclusion Criteria: * Dementia * Other neurodegenerative disease * History of substance abuse * History of hearing disorders * History of neuropsychiatric disease

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Psychology Building Hamilton Ontario

More McMaster University trials in Canada

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07647913 on ClinicalTrials.gov ↗ ← All trials in Canada